Application 212411

Type
ANDA
Sponsor
SINOTHERAPEUTICS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001POSACONAZOLEPOSACONAZOLETABLET, DELAYED RELEASE;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0527-2133POSACONAZOLEPosaconazoleLannett Company Inc.ANDACurrent
0527-2133POSACONAZOLEPosaconazoleLannett Company Inc.ANDACurrent
0527-2133POSACONAZOLEPosaconazoleLannett Company Inc.ANDACurrent
0527-2133POSACONAZOLEPosaconazoleLannett Company Inc.ANDACurrent
0527-2133POSACONAZOLEPosaconazoleLannett Company Inc.ANDACurrent
16714-156POSACONAZOLEPosaconazoleNorthStar RxLLCANDACurrent
16714-156POSACONAZOLEPosaconazoleNorthStar RxLLCANDACurrent
17856-2133POSACONAZOLEPosaconazoleATLANTIC BIOLOGICALS CORP.ANDACurrent
60687-523PosaconazolePosaconazoleAmerican Health PackagingANDACurrent
60687-523PosaconazolePosaconazoleAmerican Health PackagingANDACurrent
60687-523PosaconazolePosaconazoleAmerican Health PackagingANDACurrent
62135-429POSACONAZOLEPosaconazole Delayed-ReleaseChartwell RX, LLCANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
60208ORIG2019-10-03